AT-I has been shown to reduce the protein expression levels of phosphorylated JAK2 and phosphorylated STAT3 in A375 melanoma cells, consequently downregulating the mRNA levels of STAT3 target genes MMP-2 and MMP-9 [60]. This evidence concerns the gene STAT3 and melanoma.